Saha Pharmaceuticals Leukemia Inc is categorized under Business Management Consultants in Durham, NC and active since 2006.
Saha Pharmaceuticals Leukemia Inc was established in 2006, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Jayanta Saha at the company’s single location by writing to 104 Tw Alexander Drive # 7, Durham, North Carolina NC 27709 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Saha Pharmaceuticals Leukemia Inc |
| Contact Person: | Jayanta Saha |
| Address: | 104 Tw Alexander Drive # 7, Durham, North Carolina 27709 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Management Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Saha Pharmaceuticals Leukemia Inc was started in 2006 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Jayanta Saha for inquiries that concern Saha Pharmaceuticals Leukemia Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Saha Pharmaceuticals Leukemia Inc can be found at the coordinates 35.896706,-78.879928 as well as the street address 104 Tw Alexander Drive # 7 in Durham, North Carolina 27709.
For its online presence, you may visit Saha Pharmaceuticals Leukemia Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.